Current role
Biotechnology · Healthcare
Board Member
2023-09-08–present
Kathryn Guarini, Ph.D.
Board Member
Regeneron Pharmaceuticals, Inc. (REGN)Equibles does not estimate personal net worth.
Get an email with a short summary when Regeneron Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get REGN alertsAbout Kathryn Guarini, Ph.D.
Kathryn Guarini, Ph.D. is recorded as Board Member at Regeneron Pharmaceuticals, Inc. (REGN) since September 8, 2023. Regeneron Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Regeneron Pharmaceuticals, Inc. includes George D. Yancopoulos, M.D., Ph.D. (Chairman), Leonard S. Schleifer, M.D., Ph.D. (Chairman), Joseph J. LaRosa (General Counsel) and 7 others.
Affiliation history
-
Current
2023-09-08–present
Company network
Leadership on record at Regeneron Pharmaceuticals, Inc.
- George D. Yancopoulos, M.D., Ph.D. Chairman
- Leonard S. Schleifer, M.D., Ph.D. Chairman
- Joseph J. LaRosa General Counsel
- Christine A. Poon Board Member
- Craig B. Thompson, M.D. Board Member
- David P. Schenkein Board Member
- David P. Schenkein, M.D. Board Member
- Huda Y. Zoghbi, M.D. Board Member
- Joseph L. Goldstein, M.D. Board Member
- Kathryn Guarini Board Member
Recent activity
No call appearances or filed executive changes recorded yet.